Carcinosarcoma of the fallopian tube: Report of four cases and review of literature
Corresponding Author
Yoshihito YOKOYAMA
Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan
Dr Yoshihito Yokoyama MD, Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, 5-zaifu-cho, Hirosaki, Aomori 036-8562, Japan. Email: [email protected]Search for more papers by this authorMegumi YOKOTA
Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan
Search for more papers by this authorMasayuki FUTAGAMI
Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan
Search for more papers by this authorHideki MIZUNUMA
Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan
Search for more papers by this authorCorresponding Author
Yoshihito YOKOYAMA
Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan
Dr Yoshihito Yokoyama MD, Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, 5-zaifu-cho, Hirosaki, Aomori 036-8562, Japan. Email: [email protected]Search for more papers by this authorMegumi YOKOTA
Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan
Search for more papers by this authorMasayuki FUTAGAMI
Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan
Search for more papers by this authorHideki MIZUNUMA
Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan
Search for more papers by this authorAbstract
Aim: Carcinosarcoma of the fallopian tube is extremely rare and the therapeutic prognosis of this disease is unknown.
Methods: We report on four new cases of this disease and have reviewed 59 carcinosarcomas of the fallopian tube and analyzed the prognosis with respect to the chosen therapeutic method in order to explore the most appropriate therapy.
Results: Out of the 59 patients reviewed, the prognosis was examined in 51 patients that allowed it to be tracked. The 3-year survival rates were 63% for the 27 stage I/II patients and 40% for the 24 stage III/IV patients. The 3-year survival rates were 36% for the 14 surgery-alone patients, 59% for the 13 radiation therapy following surgery patients, 54% for the 27 chemotherapy following surgery patients (the chemotherapy group) and 100% in for the four chemoradiotherapy following surgery patients. A significant difference was observed between the surgery-alone and the chemotherapy groups (Wilcoxon test, P < 0.05), the chemoradiotherapy group demonstrating a better tendency as to survival rate than the surgery-alone group (Wilcoxon test, P = 0.06). Stage III/IV patients accounted for a two-thirds of the chemotherapy group. The 3-year survival rate for all the stage I–IV patients was 63% when a platinum drug was used and 21% when it was not used, suggesting the possibility of extending life through the use of a platinum drug.
Conclusion: Chemotherapy using a platinum drug after surgery seems to be most effective treatment in this disease.
REFERENCES
- 1 Hanjani P, Petersen RO, Bonnell SA. Malignant mixed Müllerian tumor of the fallopian tube: report of a case and review of literature. Gynecol Oncol 1980; 9: 381–93.
- 2 Henderson SR, Harper RC, Salazar OM, Rudolph JH. Primary carcinoma of the fallopian tube: difficulties of diagnosis and treatment. Gynecol Oncol 1977; 5: 168–79.
- 3 DeQuerioz AC, Roth LM. Malignant mixed Müllerian tumor of the fallopian tube: report of a case. Obstet Gynecol 1970; 36: 554–7.
- 4 Wu JP, Tanner WS, Fardal PM. Malignant mixed Müllerian tumor of the uterine tube. Obstet Gynecol 1973; 41: 707–12.
- 5 Acosta AA, Kaplan AL, Kaufman RH. Mixed Müllerian tumors of the oviduct. Obstet Gynecol 1974; 44: 84–90.
- 6
Manes JL,
Taylor HB.
Carcinosarcoma and mixed Müllerian tumors of the fallopian tube: report of four cases.
Cancer
1976; 38: 1687–93.
10.1002/1097-0142(197610)38:4<1687::AID-CNCR2820380441>3.0.CO;2-H CAS PubMed Web of Science® Google Scholar
- 7 Jain U. Mixed mesodermal tumor of the fallopian tube: report of a case and review of literature. Md State Med J 1977; 26: 43–6.
- 8 Oka M, Bassett EP, Gross S. Malignant mixed Müllerian tumors. N Y State J Med 1978; 78: 1431–4.
- 9 Viniker DA, Mantell BS, Greenstein RJ. Carcinosarcoma of the fallopian tube: a case report and review of the literature. Br J Obstet Gynaecol 1980; 87: 530–4.
- 10 Holst N, Erichsen A. Mixed mesodermal tumor of the fallopian tube: a case report. Ann Chir Gynaecol 1981; 70: 207–9.
- 11 O'Toole RV, Tuttle SE, Shah NT. Heterologous carcinosarcoma of the fallopian tube: a case report. J Reprod Med 1982; 27: 749–52.
- 12 Kahanpää KV, Laine R, Saksela E. Malignant mixed Müllerian tumor of the fallopian tube: report of a case with 5-year survival. Gynecol Oncol 1983; 16: 144–9.
- 13
Deppe G,
Zbella E,
Friberg J,
Thomas W.
Combination chemotherapy for mixed Müllerian tumor of the fallopian tube.
Cancer
1984; 54: 1517–20.
10.1002/1097-0142(19841015)54:8<1517::AID-CNCR2820540807>3.0.CO;2-V CAS PubMed Web of Science® Google Scholar
- 14 Buchino JJ, Buchino JJ. Malignant mixed Müllerian tumor of the fallopian tube. Arch Pathol Lab Med 1987; 111: 386–7.
- 15 Chen CJ, Liu HC, Ho DM, Tsay SH, Kan YY. Malignant mixed Müllerian tumor of the fallopian tube: a case report. Chin Med J (Taipei) 1988; 42: 75–80.
- 16 Kinoshita M, Asano S, Yamashita M, Matsuda T. Mesodermal mixed tumor primary in the fallopian tube. Gynecol Oncol 1989; 32: 331–5.
- 17 Axelrod JH, Herbold DR, Freel JH. Carcinosarcoma of the fallopian tube. Gynecol Oncol 1989; 32: 398–400.
- 18 Muntz HG, Rugers JL, Tarraza HM, Fuller AF Jr. Carcinosarcoma and mixed Müllerian tumor of the fallopian tube. Gynecol Oncol 1989; 34: 109–15.
- 19 Seraj IM, King A, Chase D. Malignant mixed Müllerian tumor of the oviduct. Gynecol Oncol 1990; 37: 296–301.
- 20 Liang WW, Lin YN, Lee YN. Malignant mixed Müllerian tumor of fallopian tube: report of a case and review of literature. Chin Med J (Taipei) 1990; 45: 272–5.
- 21 van Dijk CM, Kooijman CD, van Lindert ACM. Malignant mixed Müllerian tumor of the fallopian tube. Histopathology 1990; 16: 300–2.
- 22 Imachi M, Tsukamoto N, Shigematsu T et al. Malignant mixed Müllerian tumor of the fallopian tube: report of two cases and review of literature. Gynecol Oncol 1992; 47: 114–24.
- 23 Weber AM, Hewett WF, Gajewski WH, Curry SL. Malignant mixed Müllerian tumor of the fallopian tube. Gynecol Oncol 1993; 50: 239–43.
- 24
Carlson JA Jr,
Ackerman BL,
Wheeler JE.
Malignant mixed Müllerian tumor of the fallopian tube.
Cancer
1993; 71: 187–92.
10.1002/1097-0142(19930101)71:1<187::AID-CNCR2820710129>3.0.CO;2-C PubMed Web of Science® Google Scholar
- 25 Horn LC, Werschnik C, Bilek K, Emmert C. Diagnosis and clinical management in malignant Müllerian tumors of the fallopian tube. Arch Gynecol Obstet 1996; 258: 47–53.
- 26 Zorlu CG, Cobanoglu Ö, Kuscu E, Aribas D. Malignant mixed Müllerian tumor of the fallopian tube. Acta Obstet Gynecol Scand 1994; 73: 352–4.
- 27 Maitra RN, Lee J, McConnell DT, Kenwright DN, Dady P. Malignant mixed Müllerian tumor of the fallopian tube occurring in a patient with Peutz–Jegher's syndrome. Aust N Z J Obstet Gynaecol 2004; 44: 77–9.
- 28 Lim BJ, Kim JW, Yang WI, Cho NH. Malignant mixed Müllerian tumor of fallopian tube with multiple distinct heterologous components. Int J Gynecol Cancer 2004; 14: 690–3.
- 29 Moustafa M, Beynon DWG, Elmahallawy M. Primary malignant mixed Müllerian tumour of the fallopian tube. J Obstet Gynaecol 2004; 24: 940–1.
- 30 Gagner J-P, Mittal K. Malignant mixed Müllerian tumor of the fimbriated end of the fallopian tube: origin as intraepithelial carcinoma. Gynecol Oncol 2005; 97: 219–22.
- 31 Das TK, Raha K, Bandyopadhyay A, Dasgupta A, Ghosh D, Mondal AK. Malignant mixed Müllerian tumor of the fallopian tube of heterologous variety – a case report. Indian J Pathol Microbiol 2005; 48: 354–6.
- 32 Hudelist G, Unterrieder K, Kandolf O et al. Malignant mixed Müllerian tumor with heterologous component arising in the fallopian tube – a case report. Eur J Gynaecol Oncol 2006; 27: 509–12.
- 33 Nappi L, Indraccolo U, Matteo M, Rosenberg P, Greco P. Malignant mixed Müllerian tumor of fallopian tube coincident with a primary serous carcinoma of the ovary. Eur J Gynaecol Oncol 2007; 28: 511–2.
- 34 Kawaguchi W, Itamochi H, Kigawa J et al. Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed Müllerian tumor of the fallopian tube. Int J Clin Oncol 2008; 13: 461–3.
- 35 Kourea HP, Adonakis G, Androutsopoulos G, Zyli P, Kourounis G, Decavalas G. Fallopian tube malignant mixed Müllerian tumor (carcinosarcoma): a case report with immunohistochemical profiling. Eur J Gynaecol Oncol 2008; 29: 538–42.
- 36 Piura B, Rabinovich A, Apel-Sarid L, Shaco-Levy R. Carcinosarcoma of the fallopian tube with metastasis of its epithelial component to the ovary, appendix and omentum. J Obstet Gynaecol 2009; 29: 566–7.
- 37 Skafida E, Grammatoglou X, Katsamagkou E, Glava C, Firfiris N, Vasilakaki T. Primary malignant mixed Müllerian tumour of the fallopian tube. Report of a case. Eur J Gynaecol Oncol 2010; 31: 126–8.
- 38 Moore KN, Moxley KM, Fader AN et al. Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary. Gynecol Oncol 2007; 107: 398–403.
- 39 Sutton G, Brunetto VL, Kilgore L et al. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a Gynecologic Oncology Group Study. Gynecol Oncol 2000; 79: 147–53.
- 40 Curtin JP, Blessing JA, Soper JL, DeGeest K. Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol 2001; 83: 268–70.
- 41 Toyoshima M, Akahira J, Matsunaga G et al. Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus. Gynecol Oncol 2004; 94: 774–8.
- 42 Clayton Smith D, Kenneth MacDonald O, Gaffney DK. The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma. Radiother Oncol 2008; 88: 227–32.
- 43 Wada H, Enomoto T, Fujita M et al. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res 1997; 57: 5379–85.
- 44 Fujii H, Yoshida M, Gong ZX et al. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Res 2000; 60: 114–20.
- 45 Costa MJ, Vogelsang J, Young LJT. p53 gene mutation in female genital tract carcinosarcomas (malignant mixed Müllerian tumors): a clinicopathologic study of 74 cases. Mod Pathol 1994; 7: 619–27.
- 46 Menczer J, Levy T, Piura B et al. A comparison between different postoperative treatment modalities of uterine carcinosarcoma. Gynecol Oncol 2005; 97: 166–70.
Citing Literature
